BG96407A - Medicaments for local treatment of wounds and inflammatory foci - Google Patents

Medicaments for local treatment of wounds and inflammatory foci

Info

Publication number
BG96407A
BG96407A BG96407A BG9640792A BG96407A BG 96407 A BG96407 A BG 96407A BG 96407 A BG96407 A BG 96407A BG 9640792 A BG9640792 A BG 9640792A BG 96407 A BG96407 A BG 96407A
Authority
BG
Bulgaria
Prior art keywords
wounds
medicaments
local treatment
inflammatory foci
treatment
Prior art date
Application number
BG96407A
Other versions
BG60950B1 (en
Inventor
Nadja V Bogdanova
Nikolaj K Atanasov
Original Assignee
Bogdanova
Atanasov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bogdanova, Atanasov filed Critical Bogdanova
Priority to BG96407A priority Critical patent/BG60950B1/en
Publication of BG96407A publication Critical patent/BG96407A/en
Publication of BG60950B1 publication Critical patent/BG60950B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The medicaments can be used for local treatment of wounds caused from burns, radiation impairments and chemical lesions, for the treatment of atrophic and acute inflammatory processes and for pre-operative preparation of open wounds. It is a mixture of yeast transport RNA and bovine timus DNA in ratio from 1.5 to 2.5:1 in the form of a solution of gel in quantities from 0.2 to 0.3% wt.%.
BG96407A 1992-06-01 1992-06-01 Medicamentous form for wounds and skin impairments BG60950B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG96407A BG60950B1 (en) 1992-06-01 1992-06-01 Medicamentous form for wounds and skin impairments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG96407A BG60950B1 (en) 1992-06-01 1992-06-01 Medicamentous form for wounds and skin impairments

Publications (2)

Publication Number Publication Date
BG96407A true BG96407A (en) 1995-01-31
BG60950B1 BG60950B1 (en) 1996-07-31

Family

ID=3924441

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96407A BG60950B1 (en) 1992-06-01 1992-06-01 Medicamentous form for wounds and skin impairments

Country Status (1)

Country Link
BG (1) BG60950B1 (en)

Also Published As

Publication number Publication date
BG60950B1 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
PL311276A1 (en) Veterinary composition containing a proton pump inhibitor
MY110734A (en) Improvements in or relating to dioic acids.
EP0229654A3 (en) Treatment of non-acne inflammatory and infectious dermatoses
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE3685052D1 (en) PHARMACEUTICAL AND DIAET COMPOSITIONS CONTAINING LINOLE ACIDS FOR TREATING GOOD PROSTATE HYPERTROPHY.
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
PT76247A (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
BG96407A (en) Medicaments for local treatment of wounds and inflammatory foci
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
ATE44467T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING FIBRINOLYTIC AGENT AND DIFFUSION FACTOR USABLE FOR THE TREATMENT OF MYOCARDIAL INFARCTION.
IL91389A0 (en) Pharmaceutical compositions for the inhibiting of hiv containing transforming growth factors
PL315150A1 (en) Psoriasis treatment process
UA39179C2 (en) Pharmaceutical composition for treating disorders of heart rhythm in large mammalians and humans, method for its preparation and antiarrhythmic drug
PT80214A (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
Senczuk et al. Toxicodynamic properties of toluidines. Part V. Methaemoglobin-genic action of toluidines.
AU578125B2 (en) Pyrazine diazohydroxide compounds
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
MY106605A (en) Compositions for the treatment of leishmaniasis
UA15180A (en) Method for conservative treatment of generalized periodontitis
UA10210A (en) Method for treatment of urogenital clamidiosis